S-1: Origin Investment Corp I Files S-1 for $60M IPO to Pursue Asian Business Combinations

Origin Investment Corp I, a newly formed blank check company, has filed an S-1 registration statement for an initial public offering of 6 million units at $10.00 each, aiming to effect a business combination primarily with target businesses in Asia's high-growth sectors.

Summary

• Origin Investment Corp I is a blank check company formed on September 25, 2024, for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
• The company intends to offer 6,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one ordinary share and one-half of one redeemable warrant.
• The underwriters have a 45-day option to purchase up to an additional 900,000 units to cover over-allotments.
• Approximately $60,300,000 (or $69,345,000 if the over-allotment option is exercised in full) from the offering proceeds and the private placement will be deposited into a trust account, to be invested in U.S. government treasury bills or money market funds.
• The company has 21 months from the closing of the offering to consummate an initial business combination, with a potential extension to 24 months if the sponsor deposits additional funds into the trust account.
• The primary focus for target businesses will be private companies in Asia with compelling economics, clear paths to positive operating cash flow, and successful management teams seeking access to U.S. public capital markets.
• Target industries include Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, and Clean Energy.
• The company will not consummate a business combination with an entity or business in China or with China operations consolidated through a variable interest entity (VIE) structure.
• The company's sponsor, Origin Equity LLC, purchased 1,725,000 founder shares for $25,000 (approximately $0.014 per share) and will purchase 325,000 private units for $3,250,000 simultaneously with the IPO closing.
• Public shareholders will have the opportunity to redeem their shares upon completion of a business combination at a per-share price equal to the pro rata portion of funds in the trust account, anticipated to be $10.05 per public share.
• The company is an emerging growth company and a smaller reporting company, subject to reduced public company reporting requirements.

Sentiment

Score: 4

Explanation: The filing is a standard S-1 for a SPAC, outlining its structure, management, and intent. While it highlights experienced management and a clear strategy, the inherent risks of a blank check company, significant dilution for public shareholders, and potential conflicts of interest lead to a cautious sentiment. The lack of an identified target business means the investment is speculative.

Positives

• The management team and Board of Directors possess extensive experience in financial services, accounting, technology, and senior operating roles across multiple jurisdictions, including mergers and acquisitions and initial public offerings.
• The company has an established deal sourcing network, including industry executives, private owners, private equity funds, family offices, and investment bankers, which is expected to provide high-quality acquisition opportunities.
• Operating as a publicly listed acquisition company offers an attractive alternative to traditional IPOs for target businesses, potentially providing a more cost-effective and certain path to public markets, greater access to capital, and enhanced management incentives.
• The company intends to focus on high-growth industries in Asia, including Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, and Clean Energy, which are experiencing significant expansion and innovation.
• The SPAC structure may be particularly attractive in the current Asian market, where IPO proceeds dropped 33% in 2023, making de-SPAC transactions a viable alternative for private equity exits.

Negatives

• The company is a blank check company with no operating history or revenues, meaning there is no basis to evaluate its ability to achieve its business objective.
• Public shareholders will incur immediate and substantial dilution upon the closing of the offering, as the sponsor acquired founder shares at a nominal price of approximately $0.014 per share compared to the public offering price of $10.00 per unit.
• The sponsor and management team have potential conflicts of interest due to their ownership of founder shares and other business affiliations, which could incentivize them to complete a transaction even if it is not optimal for public shareholders.
• Public shareholders may not have an opportunity to vote on the proposed initial business combination, and even if a vote is held, the initial shareholders' agreement to vote in favor increases the likelihood of approval regardless of public shareholder sentiment.
• The ability of public shareholders to redeem shares for cash may make the company's financial condition unattractive to potential target businesses, potentially limiting acquisition opportunities.
• If an initial business combination is not completed within 24 months, public shares will be redeemed at approximately $10.05 per share, and warrants will expire worthless, resulting in a potential loss for investors.
• The company's limited financial resources outside the trust account ($1,700,000) may constrain its search for target businesses and ability to complete a business combination without additional financing.
• The deferred underwriting commissions will not be adjusted for redemptions, further diluting the per-share value for non-redeeming shareholders.

Risks

• Inability to complete an initial business combination within the 24-month timeframe, leading to liquidation and potential loss of investment for public shareholders.
• Significant dilution to public shareholders due to the nominal purchase price paid by the sponsor for founder shares and potential future equity issuances.
• Conflicts of interest arising from management's other business affiliations and the financial incentives tied to completing a business combination.
• Potential for the company to be deemed an investment company under the Investment Company Act, leading to burdensome compliance requirements or liquidation.
• Adverse effects on business combination search and target operations due to continued effects of the COVID-19 pandemic, global geopolitical conditions (Russia-Ukraine conflict, Middle East/Southwest Asia conflicts), and protectionist legislation.
• Risk of third-party claims reducing funds in the trust account, potentially leading to a per-share redemption amount less than $10.05.
• Uncertain U.S. federal income tax consequences for investors, including potential PFIC status and the U.S. federal excise tax on stock repurchases.
• NASDAQ delisting risk if the company fails to meet listing standards or maintain sufficient public float.
• Limited ability to assess target management and potential for combining with financially unstable or early-stage businesses.
• The company's amended and restated memorandum and articles of association may be amended with a lower shareholder approval threshold than some other SPACs, potentially facilitating changes not supported by all shareholders.
• Warrants may be redeemed prior to their exercise at a disadvantageous time, making them worthless, or may only be exercisable on a cashless basis, resulting in fewer shares received.

Future Outlook

The company intends to identify and complete an initial business combination within 21 to 24 months from the IPO closing, focusing on private companies in Asia's financial services, technology, biotechnology & pharmaceutical, advanced materials, and clean energy sectors. The strategy is to leverage the management team's expertise and network to find attractive opportunities that can benefit from access to U.S. public capital markets, aiming for significant revenue and earnings growth, strong free cash flow generation, and the advantages of being a public company.

Management Comments

• Our reputation for honesty and integrity is key to the success of our business.
• We intend that our business practices will comply with the laws of all of the jurisdictions in which we operate and that honesty, integrity and accountability will always characterize the Company's business activity.
• No employee, officer or director may achieve results through violations of laws or regulations or unscrupulous dealings.
• We believe our management team is well positioned to identify opportunities offering attractive risk-adjusted returns and that our professional contacts and transaction sources will enable us to pursue a broad range of opportunities.
• We believe that our structure and our management team's backgrounds will make us an attractive business partner.

Industry Context

The company's focus on Asia aligns with the region's sustained economic expansion, with Asian emerging markets and developing economies expected to grow 5.2% in 2024, significantly outpacing overall global growth (3.2%). The strategy to target private companies in Asia seeking U.S. public capital markets is particularly relevant given the tough IPO market and valuation environment in Asia Pacific, where IPO proceeds dropped 33% in 2023, and private equity exits through IPOs were only 13% of total PE exits in 2023 (compared to 22% over the past five years). This suggests that de-SPAC transactions could be an attractive alternative for Asian companies. The identified target industries (Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, and Clean Energy) are all characterized by transformative growth, technological advancements (e.g., generative AI, blockchain), and substantial investment, indicating a large and growing market for potential acquisitions.

Comparison to Industry Standards

• The company's unit structure, offering one ordinary share and one-half of one redeemable warrant, is designed to reduce the dilutive effect of warrants upon business combination compared to SPACs offering whole warrants, aiming to be a more attractive partner for target businesses.
• Unlike some other blank check companies, the company's amended and restated memorandum and articles of association do not provide a specified maximum redemption threshold, potentially allowing a business combination to proceed even if a substantial majority of public shareholders redeem their shares.
• The company is exempt from Rule 419 blank check company protections due to having net tangible assets exceeding $5,000,000 upon offering completion, meaning units will be immediately tradable and the company has a longer period to complete a business combination compared to Rule 419 companies.
• The company's ability to amend its charter provisions related to pre-business combination activity with a two-thirds shareholder vote is a lower threshold than some other SPACs, potentially making it easier to facilitate a business combination that some shareholders may not support.
• The company's sponsor's initial investment of approximately $0.014 per founder share is a nominal price, which is a common characteristic of SPACs but results in significant dilution for public shareholders compared to their $10.00 per unit purchase price.

Management Changes

Corporate Governance

Legal Proceedings

• No material litigation, arbitration, or governmental proceeding is currently pending against the company or any members of its management team in their capacity as such.

Related Party Transactions

• Origin Equity LLC (the Sponsor) purchased 1,725,000 founder shares for an aggregate price of $25,000 (approximately $0.014 per share) on September 25, 2024.
• The Sponsor will purchase an aggregate of 325,000 private units at $10.00 per unit for a total of $3,250,000 in a private placement concurrent with the IPO closing.
• The company will pay the Sponsor $25,000 per month for office space, administrative, and support services, ceasing upon business combination completion or liquidation.
• The Sponsor has loaned the company up to $500,000 for offering-related and organizational expenses, with $84,715 borrowed as of October 15, 2024.
• The Sponsor or its affiliates may provide working capital loans up to $1,500,000 to finance transaction costs, convertible into private units at $10.00 per unit at the lender's option.
• The Sponsor, officers, and directors will be reimbursed for out-of-pocket expenses incurred in identifying, investigating, and completing a business combination, with no cap on reimbursement.
• The company may pay finders fees, advisory fees, consulting fees, or success fees to the Sponsor, officers, directors, or their affiliates for services related to completing the initial business combination, paid from funds outside the trust account if prior to completion.

Stakeholder Impact

• **Shareholders**: Public shareholders face immediate and substantial dilution due to the sponsor's low-cost founder shares. They risk losing their investment if a business combination is not completed within the specified timeframe, as warrants would expire worthless. Redemption rights offer some protection but may be limited. Future equity issuances for business combinations could further dilute their interests.
• **Management/Sponsor**: The sponsor and management team stand to gain substantial profits from their founder shares if a business combination is successful, even if the stock price declines, creating potential conflicts of interest. They also receive monthly administrative fees and reimbursement for expenses.
• **Target Businesses**: The SPAC structure offers an alternative to traditional IPOs, potentially providing a more cost-effective and certain path to public markets, which could be attractive to private companies in Asia. However, the redemption risk by public shareholders could make the SPAC less appealing if it reduces available cash for the transaction.
• **Creditors**: Funds in the trust account are generally protected from third-party claims, but there's a risk that claims not waived by creditors could reduce the amount available for public shareholder redemptions upon liquidation.
• **Underwriters**: ThinkEquity LLC receives underwriting discounts and will be issued 30,000 ThinkEquity units, providing them with a financial interest in the successful completion of a business combination.

Next Steps

• Complete the initial public offering of 6,000,000 units.
• Apply to list units, ordinary shares, and warrants on NASDAQ.
• Identify and select one or more target businesses for an initial business combination, primarily focusing on Asia's high-growth sectors.
• Negotiate and sign a definitive agreement for the initial business combination.
• Seek shareholder approval for the business combination if required by law or stock exchange rules, or conduct a tender offer.
• Consummate the initial business combination within 21 months (or up to 24 months with extensions) from the IPO closing.
• File a post-effective amendment or new registration statement for ordinary shares issuable upon warrant exercise within 15 business days after business combination closing.
• Establish and maintain an audit committee and compensation committee upon effectiveness of the registration statement.
• Adopt a Code of Ethics and a Related Person Transactions Policy prior to the closing of the offering.

Key Dates

Keywords

SPAC, Special Purpose Acquisition Company, Blank Check Company, Initial Public Offering, IPO, Business Combination, Merger, Acquisition, Asia Market, Financial Services, Technology, Biotechnology, Pharmaceutical, Advanced Materials, Clean Energy, SEC Filing, S-1, Warrants, Dilution, Trust Account, Corporate Governance, Risk Factors